Financials data is unavailable for this security.
View more
Year on year Chemours Co 's revenues fell -11.29% from 6.79bn to 6.03bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 578.00m to a loss of 238.00m.
Gross margin | 19.53% |
---|---|
Net profit margin | 2.02% |
Operating margin | 3.43% |
Return on assets | 1.56% |
---|---|
Return on equity | 15.15% |
Return on investment | 2.08% |
More ▼
Cash flow in USDView more
In 2023, Chemours Co increased its cash reserves by 38.57%, or 503.00m. The company earned 556.00m from its operations for a Cash Flow Margin of 9.23%. In addition the company generated 172.00m cash from financing while 229.00m was spent on investing.
Cash flow per share | 2.74 |
---|---|
Price/Cash flow per share | 6.71 |
Book value per share | 4.84 |
---|---|
Tangible book value per share | 4.14 |
More ▼
Balance sheet in USDView more
Current ratio | 1.89 |
---|---|
Quick ratio | 1.01 |
Total debt/total equity | 5.52 |
---|---|
Total debt/total capital | 0.8462 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -143.77%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg) | 3.80% |
---|---|
Div growth rate (5 year) | 3.55% |
Payout ratio (TTM) | 127.59% |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 211.95 |
More ▼